Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)

Jiangsu CoWin Biotech Revenue

Jiangsu CoWin Biotech had revenue of 52.46M CNY in the quarter ending September 30, 2025, with 68.47% growth. This brings the company's revenue in the last twelve months to 167.17M, up 41.46% year-over-year. In the year 2024, Jiangsu CoWin Biotech had annual revenue of 125.88M, down -26.54%.

• Revenue (ttm): 167.17M
• Revenue Growth: +41.46%
• P/S Ratio: 18.26
• Revenue / Employee: 200.68K
• Employees: 770
• Market Cap: 3.05B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	125.88M	-45.47M	-26.54%
Dec 31, 2023	171.34M	-350.26M	-67.15%
Dec 31, 2022	521.60M	183.14M	54.11%
Dec 31, 2021	338.46M	105.25M	45.13%
Dec 31, 2020	233.21M	159.27M	215.41%